1 completed, 1 recruiting, 1 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Recruiting 1, Unknown 1 |
Follow Immunologic Factors: new trials by email Literature Review of Immunologic Factors trials Research Report on Immunologic Factors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma Anti-PD-1 monoclonal antibody, Lenalidomide, Azacitidine - Relapsed/Refractory Peripheral T-cell Lymphoma | Phase 2 | Recruiting | The First Affiliated Hospital of Soochow University | 31 | 2020-01-01 | 2026-05-01 |
| SBRT Combination With rhGM-CSF and Tα1 for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy SBRT, Immunological Agent, Immunological Factors - Lung Cancer Metastatic | Phase 2 | Unknown | The First Affiliated Hospital of Xiamen University | 48 | 2016-11-01 | 2016-11-29 |
| Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma MGN1703, Placebo - Advanced Colorectal Carcinoma | Phase 2 | Completed | Mologen AG | 59 | 2010-06-01 | 2014-06-20 |
Lung Neoplasms (1) · Lymphoma, T-Cell, Peripheral (1)
Mologen AG (1) · The First Affiliated Hospital of Soochow University (1) · The First Affiliated Hospital of Xiamen University (1)
China (2) · Austria (1) · Czechia (1) · France (1) · Germany (1) · Russia (1) · United Kingdom (1)
Depei Wu, M.D (1) · Hans-Joachim Schmoll (1)
2009 (1)